Latest Articles

Subject

Research Article
IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
Alexandre Jentzer, Arthur Attal, Clémence Roué, et al.

August 10, 2022
RESEARCH ARTICLE
Cerebellar Ataxia With Anti-DNER AntibodiesOutcomes and Immunologic Features
Elise Peter, Le Duy Do, Salem Hannoun, et al.

August 08, 2022
Correction
Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
August 03, 2022
Research Article
Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum DisordersA 14-Year Real-Life Experience
Su-Hyun Kim, Na Young Park, Ki Hoon Kim, et al.

July 19, 2022
Research Article
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
Rikke Holm Hansen, Jacob Talbot, Helene Højsgaard Chow, et al.

July 14, 2022
Correction
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
July 12, 2022
Research Article
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration
Elise Peter, Isabelle Treilleux, Valentin Wucher, et al.

July 12, 2022
Research Article
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody–Positive Stiff-Person Syndrome
Jessica Yi, Marinos C. Dalakas

July 07, 2022
Research Article
Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies
Michael Winklehner, Jan Bauer, Verena Endmayr, et al.

July 07, 2022
Clinical/Scientific Note
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies
Chiara Briani, Andrea Visentin, Francesca Castellani, et al.

July 07, 2022

Pages